SmithKline Beecham’s Paxil
Executive Summary
FDA's Psychopharmacologic Drugs Advisory Committee will review SB's Paxil NDA (20-031) as an antidepressant at its Oct. 5 meeting. Previously called Aropax, Paxil (paroxetine) was launched in five countries in 1991 under the brandname Seroxat.